SCHEMBL5112232

SCHEMBL5112232

CC(C)C(=O)Nc1cc(C#N)cc(COc2c(Br)cc(C(=O)NCC(=O)O)cc2Br)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.39
MEN1 O00255 2/20 0.39
SENP5 Q96HI0 1/20 0.38
SENP2 Q9HC62 1/20 0.38
SENP1 Q9P0U3 1/20 0.38
EGLN1 Q9GZT9 3/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
DHODH Q02127 2/20 0.35
THRA P10827 2/20 0.35
THRB P10828 2/20 0.35
MRGPRX4 Q96LA9 1/20 0.34
ITGB3 P05106 1/20 0.34
ITGA2B P08514 1/20 0.34
PTGER1 P34995 1/20 0.34
GPR139 Q6DWJ6 1/20 0.33
LMNA P02545 1/20 0.33
HPGD P15428 1/20 0.33
ANPEP P15144 1/20 0.33
LNPEP Q9UIQ6 1/20 0.33
ALDH1A1 P00352 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5106743 0.91 KMT2A (0.39) KMT2AMEN1SENP5SENP2SENP1
SCHEMBL4926820 0.89 EGLN1 (0.38) KMT2AMEN1EGLN1SMN1; SMN2DHODH
SCHEMBL5120197 0.89 EGLN1 (0.38) KMT2AMEN1SENP5SENP2SENP1
SCHEMBL5110808 0.88 SMN1; SMN2 (0.38) KMT2AMEN1SENP5SENP2SENP1
SCHEMBL4934946 0.87 SMN1; SMN2 (0.41) KMT2AMEN1EGLN1SMN1; SMN2DHODH
SCHEMBL5723352 0.87 THRA (0.41) KMT2AMEN1SENP5SENP2SENP1
SCHEMBL5110065 0.86 SENP5 (0.40) KMT2AMEN1SENP5SENP2SENP1
SCHEMBL5110890 0.86 SENP5 (0.40) KMT2AMEN1SENP5SENP2SENP1
SCHEMBL4923977 0.86 SMN1; SMN2 (0.37) KMT2AMEN1EGLN1SMN1; SMN2DHODH
SCHEMBL5111314 0.85 SENP5 (0.40) KMT2AMEN1SENP5SENP2SENP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080004251-A1 Novel Pharmaceutical Compositions Comprising Agonists of the Thyroid Receptor KARO BIO AB (SE) 2008-01-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080004251-A1 Novel Pharmaceutical Compositions Comprising Agonists of the Thyroid Receptor TSHR, TRHR, THRA KMT2A 2895/4885MEN1 806/4885SENP5 2379/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.